Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-07-05 | G1 Therapeutics, Inc. | Perry Andrew
(Chief Commercial Officer) |
S | Common Stock | D | 1337 | $2.51 - $2.51 | $3,352 |
| 2024-07-05 | G1 Therapeutics, Inc. | MURDOCK TERRY L
(Chief Operating Officer) |
S | Common Stock | D | 2475 | $2.51 - $2.51 | $6,206 |
| 2024-07-05 | G1 Therapeutics, Inc. | Malik Rajesh
(Chief Medical Officer) |
S | Common Stock | D | 2475 | $2.51 - $2.51 | $6,206 |
| 2024-07-05 | G1 Therapeutics, Inc. | Avagliano Mark
(Chief Business Officer) |
S | Common Stock | D | 2638 | $2.51 - $2.51 | $6,615 |
| 2024-07-05 | G1 Therapeutics, Inc. | Umstead John W. V
(Chief Financial Officer) |
S | Common Stock | D | 527 | $2.51 - $2.51 | $1,321 |
| 2024-07-05 | G1 Therapeutics, Inc. | Bailey John E. (J...
(President and CEO) |
S | Common Stock | D | 7662 | $2.51 - $2.51 | $19,213 |
| 2024-07-01 | G1 Therapeutics, Inc. | Perry Andrew
(Chief Commercial Officer) |
A | Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-07-01 | G1 Therapeutics, Inc. | MURDOCK TERRY L
(Chief Operating Officer) |
A | Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-07-01 | G1 Therapeutics, Inc. | Thomas Monica R.
(Chief Legal & People Officer) |
A | Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-07-01 | G1 Therapeutics, Inc. | Avagliano Mark
(Chief Business Officer) |
A | Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-07-01 | G1 Therapeutics, Inc. | Umstead John W. V
(Chief Financial Officer) |
A | Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-07-01 | G1 Therapeutics, Inc. | Bailey John E. (J...
(President and CEO) |
A | Common Stock | A | 105000 | $0.00 - $0.00 | $0 |
| 2024-06-13 | G1 Therapeutics, Inc. | Nicholson Garry A
(Director) |
A | Common Stock | A | 10000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |